Logo image of AURE.PA

AUREA (AURE.PA) Stock Fundamental Analysis

EPA:AURE - Euronext Paris - Matif - FR0000039232 - Common Stock - Currency: EUR

5.54  0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AURE. AURE was compared to 46 industry peers in the Commercial Services & Supplies industry. The financial health of AURE is average, but there are quite some concerns on its profitability. AURE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AURE had positive earnings in the past year.
AURE had a positive operating cash flow in the past year.
In multiple years AURE reported negative net income over the last 5 years.
Each year in the past 5 years AURE had a positive operating cash flow.
AURE.PA Yearly Net Income VS EBIT VS OCF VS FCFAURE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

1.2 Ratios

AURE has a better Return On Assets (2.29%) than 60.87% of its industry peers.
With a Return On Equity value of 6.19%, AURE perfoms like the industry average, outperforming 54.35% of the companies in the same industry.
Industry RankSector Rank
ROA 2.29%
ROE 6.19%
ROIC N/A
ROA(3y)3.4%
ROA(5y)1.27%
ROE(3y)9.24%
ROE(5y)3.39%
ROIC(3y)N/A
ROIC(5y)N/A
AURE.PA Yearly ROA, ROE, ROICAURE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

AURE has a Profit Margin of 1.89%. This is comparable to the rest of the industry: AURE outperforms 52.17% of its industry peers.
AURE's Profit Margin has improved in the last couple of years.
The Gross Margin of AURE (19.40%) is worse than 65.22% of its industry peers.
AURE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 1.89%
GM 19.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y8.2%
GM growth 3Y-4.16%
GM growth 5Y0.57%
AURE.PA Yearly Profit, Operating, Gross MarginsAURE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 10 15 20

6

2. Health

2.1 Basic Checks

AURE does not have a ROIC to compare to the WACC, probably because it is not profitable.
AURE has less shares outstanding than it did 1 year ago.
AURE has less shares outstanding than it did 5 years ago.
AURE has a better debt/assets ratio than last year.
AURE.PA Yearly Shares OutstandingAURE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
AURE.PA Yearly Total Debt VS Total AssetsAURE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 1.94 indicates that AURE is not a great score, but indicates only limited risk for bankruptcy at the moment.
AURE has a Altman-Z score of 1.94. This is in the better half of the industry: AURE outperforms 65.22% of its industry peers.
AURE has a debt to FCF ratio of 3.09. This is a good value and a sign of high solvency as AURE would need 3.09 years to pay back of all of its debts.
AURE has a Debt to FCF ratio of 3.09. This is amongst the best in the industry. AURE outperforms 82.61% of its industry peers.
AURE has a Debt/Equity ratio of 0.42. This is a healthy value indicating a solid balance between debt and equity.
AURE's Debt to Equity ratio of 0.42 is fine compared to the rest of the industry. AURE outperforms 71.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.09
Altman-Z 1.94
ROIC/WACCN/A
WACC5.62%
AURE.PA Yearly LT Debt VS Equity VS FCFAURE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.3 Liquidity

AURE has a Current Ratio of 1.27. This is a normal value and indicates that AURE is financially healthy and should not expect problems in meeting its short term obligations.
AURE has a Current ratio (1.27) which is in line with its industry peers.
A Quick Ratio of 0.88 indicates that AURE may have some problems paying its short term obligations.
The Quick ratio of AURE (0.88) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 0.88
AURE.PA Yearly Current Assets VS Current LiabilitesAURE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

AURE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 57.76%, which is quite impressive.
AURE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.98% yearly.
Looking at the last year, AURE shows a decrease in Revenue. The Revenue has decreased by -3.04% in the last year.
AURE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.51% yearly.
EPS 1Y (TTM)57.76%
EPS 3YN/A
EPS 5Y15.98%
EPS Q2Q%N/A
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y19.38%
Revenue growth 5Y2.51%
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, AURE will show a small growth in Earnings Per Share. The EPS will grow by 1.37% on average per year.
Based on estimates for the next years, AURE will show a quite strong growth in Revenue. The Revenue will grow by 11.42% on average per year.
EPS Next Y-4%
EPS Next 2Y-16.69%
EPS Next 3Y1.37%
EPS Next 5YN/A
Revenue Next Year-8.34%
Revenue Next 2Y18.21%
Revenue Next 3Y11.42%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AURE.PA Yearly Revenue VS EstimatesAURE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
AURE.PA Yearly EPS VS EstimatesAURE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 11.31, the valuation of AURE can be described as reasonable.
AURE's Price/Earnings ratio is rather cheap when compared to the industry. AURE is cheaper than 84.78% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. AURE is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 26.09 indicates a quite expensive valuation of AURE.
The rest of the industry has a similar Price/Forward Earnings ratio as AURE.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, AURE is valued at the same level.
Industry RankSector Rank
PE 11.31
Fwd PE 26.09
AURE.PA Price Earnings VS Forward Price EarningsAURE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AURE.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AURE indicates a rather cheap valuation: AURE is cheaper than 95.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 3.43
EV/EBITDA 10.8
AURE.PA Per share dataAURE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.71
EPS Next 2Y-16.69%
EPS Next 3Y1.37%

0

5. Dividend

5.1 Amount

No dividends for AURE!.
Industry RankSector Rank
Dividend Yield N/A

AUREA

EPA:AURE (3/7/2025, 7:00:00 PM)

5.54

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)04-29 2025-04-29/amc
Inst Owners9.04%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap52.02M
Analysts85.71
Price Target7.14 (28.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 11.31
Fwd PE 26.09
P/S 0.21
P/FCF 3.43
P/OCF 1.96
P/B 0.69
P/tB 0.8
EV/EBITDA 10.8
EPS(TTM)0.49
EY8.84%
EPS(NY)0.21
Fwd EY3.83%
FCF(TTM)1.61
FCFY29.15%
OCF(TTM)2.83
OCFY51.12%
SpS26.18
BVpS7.97
TBVpS6.9
PEG (NY)N/A
PEG (5Y)0.71
Profitability
Industry RankSector Rank
ROA 2.29%
ROE 6.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.89%
GM 19.4%
FCFM 6.17%
ROA(3y)3.4%
ROA(5y)1.27%
ROE(3y)9.24%
ROE(5y)3.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y8.2%
GM growth 3Y-4.16%
GM growth 5Y0.57%
F-Score8
Asset Turnover1.21
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF 3.09
Debt/EBITDA 4.69
Cap/Depr 110.77%
Cap/Sales 4.65%
Interest Coverage N/A
Cash Conversion 396.3%
Profit Quality 327.16%
Current Ratio 1.27
Quick Ratio 0.88
Altman-Z 1.94
F-Score8
WACC5.62%
ROIC/WACCN/A
Cap/Depr(3y)98.43%
Cap/Depr(5y)78.25%
Cap/Sales(3y)4.24%
Cap/Sales(5y)3.6%
Profit Quality(3y)84.88%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)57.76%
EPS 3YN/A
EPS 5Y15.98%
EPS Q2Q%N/A
EPS Next Y-4%
EPS Next 2Y-16.69%
EPS Next 3Y1.37%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.04%
Revenue growth 3Y19.38%
Revenue growth 5Y2.51%
Sales Q2Q%N/A
Revenue Next Year-8.34%
Revenue Next 2Y18.21%
Revenue Next 3Y11.42%
Revenue Next 5YN/A
EBIT growth 1Y-165.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.14%
EBIT Next 3Y47.85%
EBIT Next 5YN/A
FCF growth 1Y1206.05%
FCF growth 3Y22.42%
FCF growth 5Y237.51%
OCF growth 1Y176.74%
OCF growth 3Y32.74%
OCF growth 5Y27.18%